OFA in Thoracic Surgery

Launched by SHANGHAI ZHONGSHAN HOSPITAL · Sep 21, 2021

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to manage pain during lung surgery for patients with thoracic cancer, specifically focusing on a method called opioid-free anesthesia. This means that instead of using traditional strong pain medications (opioids), the study will look at how well patients do with alternative methods to manage their pain during and after surgery. The goal is to determine if this approach is safe and effective for patients undergoing surgery to remove lung tumors.

To be eligible for the trial, participants should be between the ages of 65 and 74 and need to be having specific types of lung surgery, such as lobectomy or wedge resection. They should also be able to communicate about their pain and have no significant cognitive issues or allergies to anesthesia. Participants will be closely monitored throughout the trial to assess their pain levels and overall recovery. This study is currently recruiting, and it could provide valuable information about safer pain management options for lung surgery patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • going through thoracoscopic lung surgery including lobectomy, segmentectomy, single or multiple wedge resection, and two of the above procedures combined;
• • able to complete the pain scoring face-to-face;
• • no cognitive dysfunction or history of anesthetic drug allergy;
• • ASA grade I-II
• Exclusion Criteria:
• • -psychological disorders